Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01415375 · ClinicalTrials.gov registry record · Phase 2
Prostate Cancer Education in African American Men
A Phase 2 study, sponsored by Temple University.
- Completed
- Registry status
- Phase 2
- Development phase
- 490
- Enrollment target
NCT01415375: Completed Phase 2 study, sponsored by Temple University.
NCT01415375 is a Phase 2 study that has completed, run by Temple University. The registered enrollment target is 490 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (268% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01415375, a Phase 2 study, has completed, sponsored by Temple University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 490 participants
- Enrollment target
Study Summary
This study evaluates the efficacy of a tailored telephone intervention to promote informed decision making about prostate cancer testing among predominantly immigrant black men.
Primary Outcome
Congruence between men's stated intentions to get tested and their actual testing behavior, validated by medical claims at 1 and 2 year follow-up. Intention-behavior agreement was coded as congruent (1), whereas disagreement was coded as incongruent (0).
Interventions
- BEHAVIORAL Prostate Cancer Screening Education
- BEHAVIORAL Fruit and Vegetable Intake Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 490 participants |
| Start Date | 2004-09 |
| Est. Completion | 2009-07 |
| Phase | Phase 2 |
What the finished NCT01415375 record still lists
NCT01415375 is an interventional study that assigns participants to a tested intervention. The registered 490 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (268% higher).
The record links to 0 conditions, and to 2 interventions - of which Prostate Cancer Screening Education is the first listed.
NCT01415375 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01415375 about?
NCT01415375 is a clinical study titled "Prostate Cancer Education in African American Men". This study evaluates the efficacy of a tailored telephone intervention to promote informed decision making about prostate cancer testing among predominantly immigrant black men.
What is the current status of trial NCT01415375?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 490 participants. The study started on 2004-09. Estimated completion is 2009-07.
What interventions are being tested in trial NCT01415375?
The interventions under investigation include: Prostate Cancer Screening Education (BEHAVIORAL), Fruit and Vegetable Intake Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT01415375?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01415375's enrollment target sits among peer trials
490 76th of 2000 higher than 1,925 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04728893 · 490 participants · Phase 2
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
- NCT06238479 · 490 participants · Phase 1
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
- NCT06336928 · 490 participants
A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
- NCT06641414 · 490 participants · Phase 3
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia